News

Triple Therapy Boosts HCV Response After Transplant


 

AT THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

Dr. Burton disclosed that he is an investigator in a clinical trial sponsored by Vertex Pharmaceuticals, which makes telaprevir.☐

Pages

Next Article:

Investigational HCV Regimens Ditch the Interferon